These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 27111134)

  • 21. Bipolar II disorder: current and future treatment options.
    El-Mallakh R; Weisler RH; Townsend MH; Ginsberg LD
    Ann Clin Psychiatry; 2006; 18(4):259-66. PubMed ID: 17162626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
    Altshuler LL; Suppes T; Black DO; Nolen WA; Leverich G; Keck PE; Frye MA; Kupka R; McElroy SL; Grunze H; Kitchen CM; Post R
    Am J Psychiatry; 2006 Feb; 163(2):313-5. PubMed ID: 16449487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
    Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
    Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?
    Ng B; Camacho A; Lara DR; Brunstein MG; Pinto OC; Akiskal HS
    J Affect Disord; 2008 Apr; 107(1-3):307-15. PubMed ID: 17889374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What we know and what we don't know about the treatment of schizoaffective disorder.
    Murru A; Pacchiarotti I; Nivoli AM; Grande I; Colom F; Vieta E
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):680-90. PubMed ID: 21565468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of bipolar depression.
    Musetti L; Del Grande C; Marazziti D; Dell'Osso L
    CNS Spectr; 2013 Aug; 18(4):177-87. PubMed ID: 23391164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New treatments for bipolar disorder: the role of atypical neuroleptic agents.
    Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():33-42. PubMed ID: 11154015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Child and adolescent bipolar disorder].
    Aichhorn W; Stuppäck C; Kralovec K; Yazdi K; Aichhorn M; Hausmann A
    Neuropsychiatr; 2007; 21(2):84-92. PubMed ID: 17640494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder.
    Houtepen LC; van Bergen AH; Vinkers CH; Boks MP
    Epigenomics; 2016 Feb; 8(2):197-208. PubMed ID: 26792232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of bipolar disorder in older adults.
    Sajatovic M
    Int J Geriatr Psychiatry; 2002 Sep; 17(9):865-73. PubMed ID: 12221662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of rapid-cycling bipolar disorder.
    Schneck CD
    J Clin Psychiatry; 2006; 67 Suppl 11():22-7. PubMed ID: 17029493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment-refractory bipolar disorder: classification to aid in clinical management.
    Gajwani P
    Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed features in major depressive disorder: diagnoses and treatments.
    Suppes T; Ostacher M
    CNS Spectr; 2017 Apr; 22(2):155-160. PubMed ID: 28462772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term pharmacological treatment of bipolar disorders.
    Rybakowski J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():71-93. PubMed ID: 17262006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
    Shajahan P; Taylor M
    J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological treatment of mixed states.
    Cuomo A; Nikolova VL; Yalin N; Arnone D; Fagiolini A; Young AH
    CNS Spectr; 2017 Apr; 22(2):186-195. PubMed ID: 28416033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prescribed drug use for bipolar disorder type I and II in clinical practice].
    Persson C; Kardell M; Karanti A; Isgren A; Annerbrink K; Landen M
    Lakartidningen; 2017 Jan; 114():. PubMed ID: 28094832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bipolar disorder: an update.
    El-Mallakh RS; Elmaadawi AZ; Loganathan M; Lohano K; Gao Y
    Postgrad Med; 2010 Jul; 122(4):24-31. PubMed ID: 20675968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.